Cardiothoracic & vascular anesthesia

Evaluation of Activated Clotting Times With a Heparin Reversal Protocol Designed to Conserve Protamine During Drug Shortages: A Retrospective, Cohort Study

J Cardiothorac Vasc AnesthPublished Retrospective cohort study

Main finding · First activated clotting time after initial protamine administrationResult — go to the resultDifference 1.47 s 99% CI −1.47 to 4.94

Authors' conclusion

Conservation measures regarding critical medications and supplies during times of shortages can maintain access to important services within a community.

Study context

Population
Cardiac surgical patients >18 years old who received >30,000 U of heparin, in-patient hospital setting
Participants
801 patients
Exposure
Low Dose vs Conventional Dose
Outcome
Post-reversal activated clotting times

Main finding

As reported in the abstract

First activated clotting time after initial protamine administration

Difference

1.47 s

99% CI −1.47 to 4.94

P = 0.16

By group

Low Dose vs Conventional Dose
difference 1.47 s (99% CI −1.47 to 4.94); P = 0.16

Observational data: associations, not effects.

Secondary outcomes

OutcomeDifference (mg) (99% CI)P value
Total protamine administered−100.5 (−110.0 to −91.0)P < 0.0001
OutcomeDifference (99% CI)P value
Number of protamine vials used per case (250 mg vials)−0.69 (−0.75 to −0.63)P < 0.0001
Vials used per case (50 mg vials)−2.16 (−2.36 to −1.97)P < 0.0001

Initial protamine dose

  • Number of protamine vials used per case (250 mg vials): mean vials P: p < 0.0001
  • Initial protamine dose: p < 0.0001

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Evaluation of Activated Clotting Times With a Heparin Reversal Protocol Designed to Conserve Protamine During Drug Shortages: A Retrospective, Cohort Study. J Cardiothorac Vasc Anesth. Published 18 May 2023. doi:10.1053/j.jvca.2023.05.002

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.